Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease colorectal cancer
Symptom |liver metastases
Sentences 103
PubMedID- 23302476 A clinical study on multi-disciplinary team and surgery for resectable colorectal cancer with liver metastases.
PubMedID- 25061576 Purpose: to determine the prognostic and predictive value of liver volume in colorectal cancer patients with unresectable liver metastases.
PubMedID- 22862882 Furthermore the surgical indications for liver metastases of colorectal cancer have been expanded to include all technically resectable metastases numbering 4 or more .
PubMedID- 20569442 liver metastases of 6 colorectal cancers (20.7%) had a mean pmr of 39.23% (range 25.18 to 52.18%).
PubMedID- 25319712 Purpose: the first aim of the review (aim 1) was to obtain the diagnostic performance values of (18)f-fdg pet for the detection and staging of liver metastases in patients with colorectal cancer (crc), the second aim (aim 2) was to compare pet and conventional imaging modalities, and the third aim (aim 3) was to evaluate the impact of pet on patient management.
PubMedID- 25815009 This retrospective study reports a single institution's experience of tace for metastatic colorectal cancer (mcrc) patients with unresectable liver metastases in a real-life setting.
PubMedID- 21489291 This trial focuses on patients with resectable liver metastases of colorectal cancer.
PubMedID- 25058762 This study evaluated the safety, feasibility, and short-term outcomes of simultaneous laparoscopic surgery for primary colorectal cancer with synchronous liver metastases.
PubMedID- 21126340 Specific genomic aberrations in primary colorectal cancer are associated with liver metastases.
PubMedID- 22437957 The purpose of this study was to evaluate totally laparoscopic strategies in the management of colorectal cancer with synchronous liver metastases.
PubMedID- 22966429 However, colorectal cancer patients with liver metastases resected by surgery achieve favorable survival.
PubMedID- 24889770 Management of colorectal cancer presenting with synchronous liver metastases.
PubMedID- 24959270 No significant differences were observed in the liver metastases of colorectal cancer with regard to gender, age, number of lesions, lesion size and pathological differentiation (p>0.05).
PubMedID- 23241814 Liver-first management for colorectal cancer with simultaneous liver metastases.
PubMedID- 25040974 Materials and methods: ninety-nine patients who underwent metastasectomy for liver metastases due to colorectal cancer at the department of medical oncology, 9 eylul university hospital between 1996 and 2010 were evaluated in this study.
PubMedID- 21937374 Methodology: we randomly selected 114 colorectal cancer patients with liver metastases and 114 patients without liver metastasis.
PubMedID- 22403631 investigated the influence of the egf 61*a/g polymorphism on the recurrence of liver metastases in patients with colorectal cancer and was excluded.
PubMedID- 24292449 Likewise, stromal angiopoietin-2, which is currently tested as a target for antitumour in clinical trials (mita et al, 2010; karlan et al, 2012), shows an approximately four-fold increase in colorectal liver metastases compared with primary colorectal cancer, and a two-fold upregulation in liver metastases vs lung metastases.
PubMedID- 21938482 Previous studies have suggested that plasma endostatin levels are elevated in colorectal cancer patients with liver metastases .
PubMedID- 25456112 Backgrounds: the prognostic value of biomarkers in metastatic colorectal cancer (mcrc) patients with liver metastases remains unclear.
PubMedID- 22209659 Results: synchronous liver metastases occurred in 14.7% of the colorectal cancer cases.
PubMedID- 21159103 Laparoscopic combined resection in primary colorectal cancer with synchronous liver metastases has been reported but there are no specific data for major liver resections.
PubMedID- 22096485 We investigated the effect of this protease on cell migration and angiogenesis in vitro and studied the expression of meprin-alpha mrna, protein and proteolytic activity in primary tumors at progressive stages and in liver metastases of patients with colorectal cancer, as well as inhibitory activity towards meprin-alpha in sera of cancer patient as compared to healthy controls.
PubMedID- 24106681 Prospective multicenter phase ii clinical trial of folfiri chemotherapy as a neoadjuvant treatment for colorectal cancer with multiple liver metastases.
PubMedID- 24142639 For western blot analysis, tissue samples were obtained from 10 colorectal cancer patients with synchronous liver metastases, who underwent surgical resection at the national cancer center, korea.
PubMedID- 25622583 Outcomes evaluation of laparoscopic radical coloproctectomy and hepatectomy for resectable colorectal cancer with liver metastases.
PubMedID- 24652674 Background: the optimal management of colorectal cancer with synchronous liver metastases has not yet been elucidated.
PubMedID- 22206922 Background: intensive medical treatment increases resection rate of liver metastases in patients with metastatic colorectal cancer (mcrc).
PubMedID- 25915155 Objective: in this study, we evaluate the frequency of her-2 and her-3 expression in liver metastases from patients with colorectal cancer (crlm).
PubMedID- 22934251 To address this question, sequential lung or sequential liver metastases of colorectal cancer patients were analyzed using whole slide image quantification after immunohistochemical staining against cd3, cd8, foxp3, cd68 and granzyme b. the clinical data and interventions were associated with each individual patient and the metastatic lesions.
PubMedID- 24203162 Interestingly, the expression of both pparβ/δ and cox-2 in tissues of colorectal cancer patients leads to liver metastases, a condition associated with poor prognosis (yoshinaga et al, 2011).
PubMedID- 24091673 Although 5-fu has been reported to induce apoptosis via the fas pathway in liver metastases of colorectal cancer patients,56 and stimulate p-jnk in colorectal cancer cells,57 our current results suggest the probable existence of a fas/jnk-independent mechanism in chemotherapy of 5-fu, as well as the importance of fas/jnk pathway in protection against apoptosis by adma.
PubMedID- 22739844 Introduction: for colorectal cancer patients with liver metastases involving the hepatic dome or invading the diaphragm, a concomitant diaphragm resection is often required to achieve negative surgical margins.
PubMedID- 23442595 The fact that liver metastases of colorectal cancer do not take up lipid pet tracers has already been published .
PubMedID- 23497553 The investigated patient group included nine male subjects with liver metastases of colorectal cancer (mean age 62.8 years, range 48 to 76).
PubMedID- 24606532 Pure laparoscopic right-sided hepatectomy in the semi-prone position for synchronous colorectal cancer with liver metastases.
PubMedID- 21819613 54 years-old male patient who received 1.7 gbq y-90 microsphere therapy to the right and left lobes in separate sessions for liver metastases of colorectal cancer.
PubMedID- 26566221 Early assessment of colorectal cancer patients with liver metastases treated with antiangiogenic drugs: the role of intravoxel incoherent motion in diffusion-weighted imaging.
PubMedID- 26055754 Of these patients, 12 patients had hepatocellular carcinoma, while seven patients had liver metastases of colorectal cancer (crc).
PubMedID- 24452736 Leggett et al (14) reported that the use of ctp in colorectal cancer patients with simultaneous liver metastases revealed that the hepatic arterial blood flow was significantly increased and the portal blood flow was decreased.
PubMedID- 22082538 Objective: the objectives of the study were to determine whether perfusion computed tomography (ct-p) and magnetic resonance diffusion-weighted imaging (mr-dwi) can allow evaluation of the effects of chemotherapy combined with antiangiogenetic treatment on liver metastases in patients with advanced colorectal cancer and to determine if changes in ct-p and mr-dwi correlate with the response to therapy as assessed by conventional response evaluation criteria in solid tumors (recist).
PubMedID- 21084828 Most colorectal cancer patients with liver metastases are not resectable upon initial diagnosis.
PubMedID- 26094113 Aims: the purpose of this meta-analysis is to assess the value of peri-operative chemotherapy for patients who have resectable colorectal cancer with liver metastases (crclm).
PubMedID- 22460570 The purpose of the present study was to determine whether there were differences in outcome between rfa and surgical resection in the treatment of colorectal cancer with liver metastases.
PubMedID- 23116727 The goal of this study is to assess the value of positron emission tomography/computed tomography with 18f-fluorodeoxyglucose (18f-fdg pet/ct) in the decision making whether to perform rfa or surgical resection of liver metastases in patients with metastatic colorectal cancer.
PubMedID- 24693879 Nine male patients with liver metastases of colorectal cancer were included retrospectively (age 48 to 76 years (mean 62.8), weight 73 to 100 kg (mean 85.5)).
PubMedID- 20108150 Background: hepatectomy may prolong the survival of colorectal cancer patients with liver metastases.
PubMedID- 22537902 colorectal cancer with synchronous liver metastases: does global management at the same centre improve results.
PubMedID- 26203228 In secondary cancer in liver (for instance, liver metastases of colorectal cancer), expression of nuclear cxcr4 is associated with better survival, whereas the expression of cytoplasmic cxcr4 with worse prognosis.
PubMedID- 25692420 High expression of darpp-32 in colorectal cancer is associated with liver metastases and predicts survival for dukes a and b patients: results of a pilot study.

Page: 1 2 3